The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Parkinson's disease: a dual‐hit hypothesis
Open accessAbstract
Accumulating evidence suggests that sporadic Parkinson's disease has a long prodromal period during which several non-motor features develop, in particular, impairment of olfaction, vagal dysfunction and sleep disorder. Early sites of Lewy pathology are the olfactory bulb and enteric plexus of the stomach. We propose that a neurotropic pathogen, probably viral, enters the brain via two routes: (i) nasal, with anterograde progression into the temporal lobe; and (ii) gastric, secondary to swallowing of nasal secretions in saliva. These secretions might contain a neurotropic pathogen that, after penetration of the epithelial lining, could enter axons of the Meissner's plexus and, via transsynaptic transmission, reach the preganglionic parasympathetic motor neurones of the vagus nerve. This would allow retrograde transport into the medulla and, from here, into the pons and midbrain until the substantia nigra is reached and typical aspects of disease commence. Evidence for this theory from the perspective of olfactory and autonomic dysfunction is reviewed, and the possible routes of pathogenic invasion are considered. It is concluded that the most parsimonious explanation for the initial events of sporadic Parkinson's disease is pathogenic access to the brain through the stomach and nose - hence the term 'dual-hit'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The double-hit hypothesis proposed by Hawkes et al.135 supports their theory, pointing out that a-synuclein pathology is transmitted to the midbrain through two different routes, namely, from the nasal cavity to the temporal lobe or from the stomach, followed by nasal secretions in swallowed saliva.135”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [135]
Experimental — accuracy not yet measuredIn the citing paper
“Conversely, when the α-synuclein pathology firstly occurred in the olfactory bulbs, it spread further to the brain via the olfactory tract but it also went down to the ENS and it damaged its neurons [402].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [402]
In the citing paper
“Braak and colleagues hypothesized that alpha-synuclein pathology might start in either the OB and/or in the ENS possibly by an unknown pathogen and/or environmental toxin and then progresses towards the SN and further areas in the CNS.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Hawkes et al., 2007
In the citing paper
“The vagal nerve might provide a path for the spread of alpha-synuclein pathology from the ENS to the brain through the brainstem, midbrain, basal forebrain and finally the cortical areas (Braak et al., 2003;Hawkes et al., 2007)”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Hawkes et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Self-citationThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Self-citationHummel, T., Sekinger, B., Wolf, S. R., Pauli, E., & Kobal, G. (1997) · Chemical Senses · doi:10.1093/chemse/22.1.39 · Cited by 2,501
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Self-citationPaxinos, G., & Jürgen, K. (2004) · Cited by 1,478
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Self-citationSchenck, C. H., Bundlie, S. R., & Mahowald, M. W. (1996) · Neurology · doi:10.1212/wnl.46.2.388 · Cited by 1,083
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Litvan, I., Bhatia, K. P., Burn, D. J., Goetz, C. G., Lang, A. E., McKeith, I. G., Quinn, N. P., Sethi, K. D., Shults, C. W., & Wenning, G. K. (2003) · Movement Disorders · doi:10.1002/mds.10459 · Cited by 1,011
Research works printed but not linked: 4
- Braak H, 2005, Parkinson's Disease: Progress in Research., 1
- Sulla M, 1996, Gastric emptying time and gastric motility in patients with untreated Parkinson's disease, Mov Disord, 11, 1041
- Schenck CH, 2003, REM behavior disorder (RBD), delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum & maximum tonic and/or phasic electromyographic abnormalities found during REM sleep, Sleep, 26, 316
- 10.1042/bse0410139 · DOI
Cited by
Sorted by citations
Items 701–800 of 1,000
Persistent intolerable abdominal pain in patients with Parkinson’s disease
Kataoka, H., & Sugie, K. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107558 · Cited by 5
The influence of zwitterionic and anionic phospholipids on protein aggregation
Ali, A., Dou, T., Holman, A. P., Hung, A., Osborne, L., Pickett, D. N., Rodriguez, A., Zhaliazka, K., & Kurouski, D. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107174 · Cited by 5
Ebina, J., Mizumura, S., Morioka, H., Shibukawa, M., Nagasawa, J., Yanagihashi, M., Hirayama, T., Ishii, N., Kobayashi, Y., Inaba, A., et al. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.122932 · Cited by 5
Farid, I., Ali, A., Holman, A. P., Osborne, L., & Kurouski, D. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130632 · Cited by 5
Pham, T., Schelling, R. E., & Loh, K. H. (2025) · Advances in genetics · doi:10.1016/bs.adgen.2025.02.001 · Cited by 5
From Molecule to Clinic and Community for Neurodegeneration: Research to Bridge Translational Gaps
Brayne, C., Barker, R. A., Harold, D. H., Ince, P. G., Savva, G. M., Williams, J. H., Williams‐Gray, C. H., & Wharton, S. B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129006 · Cited by 5
Neuropeptide-S prevents 6-OHDA-induced gastric dysmotility in rats
Sinen, O., Özkan, A., Ağar, A., & Bülbül, M. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147442 · Cited by 5
How Lazy Reading and Semantic Sloppiness May Harm Progress in Synucleinopathy Research
Bézard, E. (2022) · Biomolecules · doi:10.3390/biom12020228 · Cited by 5
Niklasson, B., Lindquist, L., Klitz, W., Fredrikson, S., Morgell, R., Mohammadi, R., Bank, N. B., Karapetyan, Y. E., & Englund, E. M. (2022) · Microorganisms · doi:10.3390/microorganisms10030599 · Cited by 5
Gastrointestinal Biopsy Obtained During Cancer Screening, a Biological Marker for α-Synucleinopathy?
Jotanovic, J., Milin-Lazovic, J. S., & Alafuzoff, I. I. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac023 · Cited by 5
Horsager, J., Okkels, N., Fedorova, T. D., Knudsen, K., Skjærbæk, C., Berge, N. V. D., Jacobsen, J., Munk, O. L., Danielsen, E. H., Bender, D., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.09.016 · Cited by 5
Aggregation of alpha-synuclein in enteric neurons does not impact function in vitro
Bindas, A. J., Nichols, K. N., Roth, N. J., Brady, R., Koppes, A. N., & Koppes, R. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-26543-x · Cited by 6
LRRK2 Parkinsonism: Does the Response to Gut Bacteria Mitigate the Neurological Picture?
Menozzi, E., Macnaughtan, J., & Schapira, A. H. V. (2020) · Movement Disorders · doi:10.1002/mds.28347 · Cited by 5
Fishing for synucleinopathy models
Noor, S. M., & Norazit, A. (2022) · Fisheries and aquatic sciences · doi:10.47853/fas.2022.e11 · Cited by 4
Bacterial products initiation of alpha-synuclein pathology: an in vitro study
Ioghen, O. C., Gaina, G. F., Lambrescu, I. M., Manole, E., Pop, S., Niculescu, T., Mosoia, O., Ceafalan, L. C., & Popescu, B. O. (2024) · Scientific Reports · doi:10.1038/s41598-024-81020-x · Cited by 4
Sharma, N., & An, S. S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136468 · Cited by 5
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review
Carrossa, G., Misenti, V., Faggin, S., Giron, M. C., & Antonini, A. (2025) · Biomedicines · doi:10.3390/biomedicines13071769 · Cited by 4
Deng, I. B., Garg, S., Zhou, X., & Bobrovskaya, L. (2022) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1402013 · Cited by 4
Early clinical features of the parkinsonian-related dementias
Katz, M., Pressman, P., & Boeve, B. F. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.018 · Cited by 4
Bacterial overgrowth syndrome with hyperammonemia as a cause of cognitive disorders
Вологжанина, Л. Г., Бородина, Е. Н., Игумнова, О. А., & Trapeznikova, A. А. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-186-2-79-87 · Cited by 4
Visanji, N. P., Kovács, G. G., & Lang, A. E. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13312 · Cited by 4
Diffusion tensor imaging‐based pontine damage as a degeneration marker in synucleinopathy
Chung, S. J., Cho, K. H., Lee, Y. H., Yoo, H. S., Baik, K., Jung, J. H., Ye, B. S., Sohn, Y. H., Cha, J., & Lee, P. H. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24926 · Cited by 4
Rethinking Parkinson Disease: Exploring Gut-Brain Interactions and the Potential Role of Exercise
Zapanta, K., Schroeder, E. T., & Fisher, B. E. (2022) · Physical Therapy · doi:10.1093/ptj/pzac022 · Cited by 5
Spotlight on non-motor symptoms and Covid-19
Rota, S., Boura, I., Wan, Y.-M., Lazcano‐Ocampo, C., Rodríguez‐Violante, M., Antonini, A., & Chaudhuri, К. R. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.001 · Cited by 4
Infectious hypothesis of neurodegenerative diseases. What waits us after the COVID-19 pandemic?
Litvinenko, I., Lobzin, V. Y., Pushkarev, V. A., & Skripchenko, N. V. (2022) · Russian neurological Journal · doi:10.30629/2658-7947-2022-27-3-64-73 · Cited by 5
El‐Mansoury, B., Smimih, K., Khiat, A. E., Fatimi, H. E., Aimrane, A., Baz, S. E., Elmourid, A., Saad, F. E.-Z., Ghachi, H. E., Khanouchi, M., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5156-4.ch017 · Cited by 4
Sadoc, M., Clairembault, T., Coron, E., Berthomier, C., Dily, S. L., Vavasseur, F., Pavageau, A., Louis, E. K. S., Péréon, Y., Neunlist, M., et al. (2023) · SLEEP · doi:10.1093/sleep/zsad310 · Cited by 5
Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue
Erdmann, L., Santos, P. I., Rieper, P., Klafki, H., Beutner, D., Wiltfang, J., Outeiro, T. F., & Setz, C. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230379 · Cited by 5
The Universal Non-Neuronal Nature of Parkinson's Disease: A Theory
Valente, A. X. C. N., Adilbayeva, A., Tokay, T., & Rizvanov, A. A. (2016) · Central Asian Journal of Global Health · doi:10.5195/cajgh.2016.231 · Cited by 4
Struktur und Efferenzen der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom
Urban, P. P., Falkenburger, B. H., Jost, W. H., Ransmayr, G. N., Riederer, P. F., & Winkler, C. (2020) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1149-9280 · Cited by 4
Sakakibara, R., Fowler, C. J., & Hattori, T. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762611.014 · Cited by 4
Unlocking the Secrets of Lrrk2 Function With Selective Kinase Inhibitors
Dzamko, N. L., & Halliday, G. M. (2013) · Future Neurology · doi:10.2217/fnl.13.9 · Cited by 4
Non‐Dopaminergic Pathology of Parkinson's Disease
Braak, H., & Tredici, K. D. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch3 · Cited by 4
Self-citationBoertien, J. M., Nazmuddin, M., Kłos, J., Slomp, A. C., van der Zee, S., Borra, R., & van Laar, T. (2022) · medRxiv · doi:10.1101/2022.12.23.22283910 · Cited by 4
Mercado, G., Clabout, A.-C., Howland, V., Arkin, E., Janer, A. B., Plessers, D., Steiner, J. A., Smith, W. W., Hannan, T. J., Brundin, P., et al. (2024) · Journal of Parkinson s Disease · doi:10.1177/1877718x241289046 · Cited by 4
Paudel, P., & Sah, A. (2025) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2025.100374 · Cited by 3
Figliomeni, A., Winter, S. J., Abonnel, M. Y., Kenna, J. E., Lodge, S., Whiley, L., Bernal, A., Coudert, J. D., Noonan, J. E., Kaskow, B. J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01212-8 · Cited by 3
Parkinson’s Disease: Contemporary Concepts and Clinical Management
Carvalho, V., Cunha, C. V., & Massano, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_17 · Cited by 3
Seo, M. H., Kim, S.-H., & Yeo, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-51770-9 · Cited by 3
Liu, W., Zhou, W., Zhao, P., Wu, T., Gu, H., Li, Y., Zhong, C., Bai, H., Zhao, N., & Huang, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04076-w · Cited by 3
Kleinz, T., Scholz, L., Huckemann, S., Rohmann, R., Kuhn, E. M., Averdunk, P., Kools, S., Hilker, L., Bieber, A., Müller, K., et al. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241267300 · Cited by 3
Diagnosis of Parkinson’s disease: progress and future prospects
Goldman, J. G., & Patel, R. A. (2015) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s62065 · Cited by 3
Dietary interventions in Parkinson’s disease: An update
Pavan, S., Prabhu, A., Gorthi, S. P., Shetty, V., Rajesh, V., Hegde, A., & Ballal, M. (2022) · Biomedicine · doi:10.51248/.v42i3.1639 · Cited by 3
Appearance of extrapyramidal symptoms in adolescent psychiatry patients during COVID‐19 infection
Tonyali, A., Karaçetin, G., Yesilkaya, C., Arik, F. N. T., & Ocakoğlu, B. K. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28556 · Cited by 3
Datta, A. K., Mukherjee, A., & Biswas, A. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_767_22 · Cited by 3
Neurotoxic Effects of Airborne Particulate Matter: Mechanisms and Health Implications
Thangavel, P., Park, D., & Lee, Y. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70322 · Cited by 3
Modeling synucleinopathies in rodents
Janer, A. B., Vonck, E., & Baekelandt, V. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.09.001 · Cited by 3
Ekimova, I. V., Belan, D. V., Lapshina, K. V., & Pastukhov, Y. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89833-1.00008-2 · Cited by 3
Gastric Dysfunction in Parkinson’s Disease
Rozenberg, A., Gurevich, T., Giladi, N., & Korczyn, A. D. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-429-6_9 · Cited by 3
Clinicopathological Correlates of Lewy Body Disease: Fundamental Issues
Ahn, T. (2010) · Journal of Movement Disorders · doi:10.14802/jmd.10003 · Cited by 3
Understanding Parkinson disease
Vernon, G. M., Carty, A. E. S., Salemno, C. M., Siskind, M. M., & Thomas, C. A. (2014) · The Nurse Practitioner · doi:10.1097/01.npr.0000453646.44157.83 · Cited by 3
Parkinson’s Disease: Diagnosis, Motor Symptoms and Non-motor Features
Jankovic, J. J. (2013) · doi:10.2217/9781780843391 · Cited by 4
Prion-Like Propagation in Neurodegenerative Diseases
Peelaerts, W., Baekelandt, V., & Brundin, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00008-0 · Cited by 3
Shin, C., Yang, H., Park, S., Lee, H., Kong, S., Suh, Y., Huh, Y., Kim, Y. J., Park, S.-Y., Ahn, T., et al. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.05.033 · Cited by 3
Nomura, T., Nomura, Y., Oguri, M., Hirooka, Y., & Hanajima, R. (2020) · eNeurologicalSci · doi:10.1016/j.ensci.2020.100261 · Cited by 3
Early clinical features of the parkinsonian-related dementias
Boeve, B. F. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.015 · Cited by 3
Sonne, J. H. (2013) · UKnowledge (University of Kentucky) · Cited by 3
Donepezil and α‐synuclein Constipation: A 60 Month Follow-Up
Lepkowsky, C. M. (2022) · POJ Clinical Case Reports · doi:10.32648/2639-3298/4/1/1 · Cited by 2
Iyengar, A. S., Dunkley, P. R., & Dickson, P. W. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578755 · Cited by 3
Wei, J., Wang, L., Wang, D., Chen, W., Guo, L., Ren, M., Guo, F., Ruan, S., Hu, H., Zheng, Y., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01135-4 · Cited by 2
Kidney Impairment and α-Synucleinopathy: Implications for Assessment and Treatment
Lepkowsky, C. M. (2025) · The American Journal of Geriatric Psychiatry Open Science Education and Practice · doi:10.1016/j.osep.2025.10.001 · Cited by 2
Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson’s disease
Mohamed, Y. A., Nadeem, A. A. A., Ismail, L. M., Ghallab, Y. K., Ouédraogo, R. J., Elhelw, J., Ahmed, M., & Tharwat, E. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.012 · Cited by 2
Bang, C. S., Hasanuzzaman, M., Lee, J. J., & Gong, E. J. (2026) · European Journal of Clinical Investigation · doi:10.1111/eci.70164 · Cited by 2
Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe
Sim, R. R. Y., Lee, J., Chieng, J., Tan, K. H., Lim, G., Foo, A. S. C., Wong, H. S., Lim, K. L., & Liang, K. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00069 · Cited by 1
Mou, Y., Li, Q., Wang, Y., Song, X.-Y., Wang, H., Liu, W.-C., Cheng, Y.-C., Shen, H., Ren, C., & Song, X.-C. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s585021 · Cited by 2
Kuang, Y., Mao, H., Lin, H., Dai, W., Su, Z., Luo, Y., Zou, W., Yang, X., & Xu, P.-Y. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02322-x · Cited by 2
Donepezil for α‐synuclein Constipation: An 18 Month Follow-Up
Lepkowsky, C. M. (2018) · POJ Clinical Case Reports · doi:10.32648/2639-3298/1/1/003 · Cited by 2
Cancela, J., Pastorino, M., & Arredondo, M. T. (2017) · IGI Global eBooks · doi:10.4018/978-1-5225-3158-6.ch050 · Cited by 2
The theoretical problems of “prodrome” and “phenoconversion” in neurodegeneration
Sturchio, A., & Espay, A. J. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85538-9.00002-x · Cited by 2
Prevalence and Distribution of Lewy Pathology in a Homeless Population
Danics, K., Visanji, N. P., Ichimata, S., Mathur, S., Sára-Klausz, G., & Kovács, G. G. (2023) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2023.291 · Cited by 2
Influencia de la microbiota intestinal en la enfermedad de Parkinson: revisión bibliográfica
Gomez, A. B. M., Vera, V. M. S., Salluco, N. F. C., & Copa, J. B. M. (2023) · REVISTA PERUANA DE CIENCIAS DE LA SALUD · doi:10.37711/rpcs.2023.5.3.422 · Cited by 4
Катунина, Е. А., Semenova, A. M., & Katunin, D. A. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412401138 · Cited by 2
Wang, F., Zhang, Z., Sun, Y., Li, Y., Guo, T., Pan, Y., Ding, S., Jiang, L. H., & Liu, H. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.05.09 · Cited by 2
Yoo, S., Ryu, D.-W., Oh, Y., Ha, S., Lyoo, C. H., & Kim, J. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12586-9 · Cited by 2
The biological basis of Parkinson's disease: A comprehensive review
Guessoum, A., Abouelsoud, M., & Khirani, I. (2024) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2024.12.2.1473 · Cited by 5
Lee, D., Yamazaki, Y., Kuwamizu, R., Okamoto, M., & Soya, H. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121139 · Cited by 3
Figura, M., & Fatokun, A. A. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100861 · Cited by 3
Avagyan, S., Muradyan, A., Makletsova, M. G., Полещук, В. В., & Zilfyan, A. (2025) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-3.19v.2025-4 · Cited by 2
Brooks, P. L., Visanji, N. P., Hazrati, L., & Lang, A. E. (2012) · Basal Ganglia · doi:10.1016/j.baga.2012.05.004 · Cited by 2
Kim, Y. S. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.2.264 · Cited by 2
Norazit, A., Mellick, G. D., & Meedeniy, A. C. B. (2012) · InTech eBooks · doi:10.5772/33459 · Cited by 2
Neuroanatomical and neurophysiological foundations of the human olfactory system
Mydlikowska-Śmigórska, A., & Śmigórski, K. (2016) · Neuropsychiatria i Neuropsychologia · doi:10.5114/nan.2016.65643 · Cited by 3
Olfactory dysfunctions occurring in the course of Parkinson’s disease
Śmigórski, K., & Mydlikowska-Śmigórska, A. (2017) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2017.69376 · Cited by 2
The relationship between inflammatory bowel disease and Parkinson’s disease: true or fiction?
Carmona‐Abellán, M., Rodríguez–Lago, I., Cabriada, J. L., & Gómez‐Esteban, J. C. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1641739 · Cited by 2
A review on factors causing parkinson’s syndrome
Piramanayagam, S., & Selvaraj, S. (2018) · MOJ Proteomics & Bioinformatics · doi:10.15406/mojpb.2018.07.00243 · Cited by 2
Neuropathology of Movement Disorders
Jellinger, K. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00076-9 · Cited by 2
Gut-brain axis: Review on the association between Parkinson’s disease and plant lectins
Moin, K., Funk, C. M., & Josephs, M. (2022) · Archive of Clinical Cases · doi:10.22551/2022.37.0904.10228 · Cited by 2
Detecting α-synuclein seeds in serum to diagnose synucleinopathies
(2023) · Nature Medicine · doi:10.1038/s41591-023-02402-8 · Cited by 2
Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies
Trubitsina, N. P., Matiiv, A. B., Rogoza, T. M., Zudilova, A. A., Bezgina, M. D., Zhouravleva, G. A., & Bondarev, S. A. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924030118 · Cited by 2
Donepezil and α-synuclein Constipation: A 36 Month Follow-Up
Lepkowsky, C. M. (2019) · POJ Clinical Case Reports · doi:10.32648/2639-3298/2/1/002 · Cited by 2
Damodharan, N. S., Kumar, V. S., Horst, P., Nadine, W., & Hegelmaier, T. (2020) · International Journal of Ayurveda and Pharma Research · doi:10.47070/ijapr.v8isupply1.1644 · Cited by 2
Gómez-Chavarı́n, M., & Morales-Gómez, M. R. (2017) · Archivos de Neurociencias · doi:10.31157/an.v22i2.153 · Cited by 2
Bentea, L., Ölveczky, P. C., & Bentea, E. (2014) · NORA - Norwegian Open Research Archives · Cited by 2
Does REM sleep behavior disorder have the guts to be Parkinson disease?
Unger, M. M., & Sakakibara, R. (2015) · Neurology · doi:10.1212/wnl.0000000000002130 · Cited by 2
Intranasal delivery of GDNF for the treatment of Parkinson's disease
Migliore, M. M. (2008) · doi:10.17760/d10018463 · Cited by 2
Fowler, C. J., Panicker, J. N., & Emmanuel, A. V. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762611.013 · Cited by 2
Conjugal multiple system atrophy: Computing chance or investigating real patients?
Nan, H., Natori, T., Ichinose, Y., Koh, K., & Takiyama, Y. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.03.005 · Cited by 2
Duda, J. E., & Stern, M. B. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch28 · Cited by 2
Lard, M., deol, S., Dhanawat, M., Mehta, D. K., Das, R., Gupta, S., Morsy, M. A., Nair, A. B., Matouk, A. I., & Gupta, N. (2022) · Research Square · doi:10.21203/rs.3.rs-2228676/v1 · Cited by 2
Hypothesis of Ascension in Idiopathic Parkinson’s Disease
Klingelhoefer, L., & Reichmann, H. (2017) · Neurology International Open · doi:10.1055/s-0043-102389 · Cited by 1
Metadata
- Authors
- Hawkes, C. H., Del Tredici, K., & Braak, H.
- Affiliations
- Queen's Hospital (GB)
- Goethe University Frankfurt (DE)
- Corresponding author
- Hawkes, C. H.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2007-10-24
- Volume
- 33
- Issue
- 6
- Pages
- 599-614
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- PMC
- PMC7194308
- OpenAlex
- W2105047187
- Cited by
- 1,021
- References
- 163
- Citations by year
- 2026: 35 · 2025: 59 · 2024: 87 · 2023: 82 · 2022: 104 · 2021: 117 · 2020: 83 · 2019: 59 · 2018: 49 · 2017: 63 · 2016: 41 · 2015: 33 · 2014: 32 · 2013: 40 · 2012: 33
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, neurotropic viruses, olfactory dysfunction, Lewy bodies, vagal dysfunction, sleep disorder, olfactory bulb, submucosal plexus, vagus nerve, substantia nigra, prodromal Parkinson's disease, viral pathogenesis
- MeSH terms
- Animals, Olfaction Disorders, Gastrointestinal Diseases, Heart Diseases, Humans, Models, Neurological, Parkinson Disease, Sleep Wake Disorders, Virus Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
